Z-0359-2027 Class II Ongoing

Recalled by Luminex Corporation — Northbrook, IL

FDA device recall Z-0359-2027 was initiated by Luminex Corporation on Oct 5, 2026 and is designated Class II. Reason for recall: Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed… The recall status is ongoing. Affected quantity: 30,168 test cartridges (2,514 Kits).

Recall details

Product Type
Devices
Report Date
Nov 11, 2026
Initiation Date
Oct 5, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30,168 test cartridges (2,514 Kits)

Product description

LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303

Reason for recall

Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of bloodstream infection.

Distribution pattern

US distribution nationwide. No OUS distribution.

Code information

All lots UDI-DI pending

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0359-2027
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Luminex Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0359-2027. Report a data issue: hello@regdatalab.com.